1,038 results found

Welcome to the June 2025 edition of our Life Sciences and Healthcare Newsletter, where we delve into the latest developments shaping the industry.

The Union Budget 2025-26 was presented by the Government of India on February 1, 2025, outlining the government's vision for accelerating economic growth, boosting investments, and ensuring inclusive

One of the potential threats for manufacturing and sale of food/health supplements such as "Dietary food supplement", "Food supplements", "Nutritional supplements", "Health supplements", is its categorization in the category of "Food" or "Drugs", as there is a very thin line between "drugs/ medicines" and "nutritional supplements".

India's pharmaceutical and healthcare regulatory landscape in August 2026 witnessed significant reforms spanning medical devices, drug safety, clinical trials, and professional registration. From stricter controls on pediatric medications to streamlined ethics review processes, these developments reshape compliance obligations and market access pathways for life sciences stakeholders.

India's pharmaceutical sector continues to demonstrate robust growth momentum, with the market reaching USD 50.41 billion in 2024 and growing at approximately 10% annually.

In the context of patents, the term "unpredictable arts" refers to fields where the outcomes of experiments or innovations are not easily predictable.

Welcome to the September 2024 edition of our Life Sciences and Healthcare Newsletter, where we delve into the latest developments shaping the industry.

The recent developments in the healthcare and pharma industry primarily focuses on high quality pharmacy education and equitable access to healthcare coupled with classification of certain new medical devices.

This newsletter provides a comprehensive overview of recent developments, advisories, and key judgments related to food safety and regulatory compliance in India.

Erleada will be available as 60-mg tablets.

Applications will only be accepted from commercial manufacturers, including international manufacturers or their authorised Indian subsidiaries

The Food Safety and Standards Authority of India (FSSAI), India's food regulator has issued new norms for the import, labelling and packaging of products imported to India...

In general, digital health in India refers to the tools and services used for health services with the help of information and communication technologies,...

Over the past year and a half, the COVID-19 pandemic has posed a multitude of challenges and opportunities for the pharma industry.

The India-New Zealand Free Trade Agreement (FTA) entered into force on 20 October 2026, marking a significant development in the economic relationship between the two countries. Signed in New Delhi on 27 April 2026, the agreement seeks to expand bilateral trade, improve market access, encourage investment and create new opportunities for businesses, skilled professionals and students.

The Indian Medical Device industry has shown remarkable variation in its synthesis of demand and supply.

In a significant ruling between Food Safety and Standards Authority of India v. G. Subramania Koushik & Ors. addressing consumer awareness and food safety, the Madras High Court has upheld its earlier directions requiring precautionary labelling on plastic/PET-bottled drinking water and sugar and salt sold in plastic packaging, indicating the possible presence of microplastics and nanoplastics. The decision highlights the importance of consumer disclosure, particularly where scientific research has identified potential health concerns but the precise extent of the associated risks remains under investigation.

Telemedicine basically means "healing at a distance". It is great for both patients and medical assistance provider. That there is no one definitive definition of telemedicine – a 2007 study...